Overview

Growth Response in Short Children Suffering From a Disease With Growth Retardation and Treated With Somatropin

Status:
Completed
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
Growth hormone therapy will improve the height of short statured children with pathological conditions that lead to growth retardation. Growth hormone therapy will show an increase in height velocity >1 SD compared to pretreatment height velocity. and the therapy will be safe.
Phase:
Phase 2
Details
Lead Sponsor:
University of Erlangen-Nürnberg Medical School